/Companies

Cesca Therapeutics

Rancho Cordova, US · Delaware corporation

Find your way into Cesca Therapeutics

Sign up to see every warm intro you have to Cesca Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cesca Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

KP
Kenneth PappaExecutive
KH
Kenneth HarrisExecutive
MS
Mitchel SivilottiExecutive
MB
Mike BruchExecutive
RC
Robin C StaceyExecutive

Board

MR
Michael RheinBoard director
CW
Craig W MooreBoard director
MR
Mahendra RaoBoard director

Reported raises · per SEC filings

Form D private placements

$34.6M disclosed across 5 rounds · 2014–2023

▶$3MraisedMar 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Xiaochun XuExecutive Officer, Director
  • Haihong ZhuExecutive Officer, Director
  • Joseph ThomisDirector
  • Russell MedfordDirector
  • Vivian LiuDirector
  • Jeffery CaubleExecutive Officer
Offering amount
$3M
Amount sold
$3M
Sales commissions
$300K
Placement agents
H.C. Wainwright & Co., LLC.
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$800KraisedFeb 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffery CaubleExecutive Officer
  • Joseph ThomisDirector
  • Xiaochun XuExecutive Officer, Director
  • Russell MedfordDirector
  • James XuDirector
  • Mark WestgateDirector
Offering amount
$800K
Amount sold
$800K
Minimum investment
$800K
First sale
Jan 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$816.9KraisedApr 2018 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Russell MedfordDirector
  • Vivian LiuExecutive Officer, Director
  • Joseph ThomisDirector
  • Jeff CaubleExecutive Officer
  • Mark WestgateDirector
  • James XuDirector
  • Xiaochun XuExecutive Officer, Director
Offering amount
$816.9K
Amount sold
$816.9K
Sales commissions
$96.9K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedFeb 2016 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Craig W. MooreDirector
  • Robin StraceyExecutive Officer, Director
  • Michael BruchExecutive Officer
  • Denis Michael RheinDirector
  • Mahendra S. RaoDirector
Offering amount
$15M
Amount sold
$15M
First sale
Feb 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedSep 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael RheinDirector
  • Craig W MooreDirector
  • Kenneth PappaExecutive Officer
  • Mahendra RaoDirector
  • Kenneth HarrisExecutive Officer, Director
  • Mitchel SivilottiExecutive Officer
  • Mike BruchExecutive Officer
  • Robin C StaceyExecutive Officer, Director
Offering amount
$15M
Amount sold
$15M
Sales commissions
$1.2M
Placement agents
Maxim Group LLC
First sale
Aug 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Cesca Therapeutics raised?
Cesca Therapeutics has disclosed $34.6M raised across 5 rounds.
Where is Cesca Therapeutics headquartered?
Cesca Therapeutics is headquartered in Rancho Cordova, US.